Composition useful for the prevention of adverse effect due to the use of PPARgamma agonists
Details for Australian Patent Application No. 2008253134 (hide)
International Classifications
Event Publications
3 December 2009 PCT application entered the National Phase
PCT publication WO2008/141897 Priority application(s): WO2008/141897
Legal
The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.
Next and Previous Patents/Applications
2008253154-3,3-spiroindolinone derivatives
2008253125-Oral dosage form providing fast absorption of drug
IP Reporting Samples
Customised IP Reporting
IP Insider for IP Professionals
IP Monitor Professional
- Editable Word format reports
- For IP Professionals
- Multiuser